GPT Healthcare Limited (NSE:GPTHEALTH)
India · Delayed Price · Currency is INR 156.02
+0.76 (0.49%)
Sep 9, 2025, 3:29 PM IST
GPT Healthcare Revenue
GPT Healthcare had revenue of 1.07B INR in the quarter ending June 30, 2025, with 9.50% growth. This brings the company's revenue in the last twelve months to 4.16B, up 3.63% year-over-year. In the fiscal year ending March 31, 2025, GPT Healthcare had annual revenue of 4.07B with 1.72% growth.
Revenue (ttm)
4.16B
Revenue Growth
+3.63%
P/S Ratio
3.07
Revenue / Employee
2.16M
Employees
1,924
Market Cap
12.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4.07B | 68.98M | 1.72% |
| Mar 31, 2024 | 4.00B | 391.56M | 10.85% |
| Mar 31, 2023 | 3.61B | 236.22M | 7.00% |
| Mar 31, 2022 | 3.37B | 946.62M | 39.00% |
| Mar 31, 2021 | 2.43B | 309.09M | 14.59% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Divi's Laboratories | 96.52B |
| Cipla | 274.80B |
| Apollo Hospitals Enterprise | 225.51B |
| Mankind Pharma | 129.10B |
| Zydus Lifesciences | 236.08B |
| Fortis Healthcare | 80.94B |
| Alkem Laboratories | 133.04B |
GPT Healthcare News
- 4 months ago - GPT Healthcare commissions 158-bed quaternary care hospital in Raipur, Chhattisgarh - Business Upturn
- 10 months ago - GPT Healthcare Q2 FY25 Results: Revenue down 2.1% YoY to Rs 108.47 crore, Net Profit falls 10.5% YoY - Business Upturn